Iowa Post-Baccalaureate Research Education in the Biomedical Sciences

爱荷华州生物医学学士后研究教育

基本信息

  • 批准号:
    9910429
  • 负责人:
  • 金额:
    $ 24.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2021-11-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This is a new application from the University of Iowa (U Iowa) for an R25 Post-baccalaureate Research Education Program (PREP). It draws upon the collective talent and commitment of >40 experienced faculty to provide an exceptional experience to 10 talented participants each year who are members of under- represented (UR) groups. This application is based on an innovative employment initiative undertaken two years ago that enabled recent college graduates with career aspirations in the health professions and biomedical sciences to secure research positions in laboratories for 1-2 years without competing for positions with career research staff. The program has been a great success. With this experience, we are now positioned to develop a program specific to individuals interested in the PhD or MD/PhD. This mechanism will provide the financial support, infrastructure, resources, and programmatic activities necessary to enhance the qualifications and experiences of its participants, making them highly competitive for top-tier graduate programs - including those at U Iowa. The program includes an introductory class in fundamental laboratory skills, followed by two 3-week research rotations, selection of a laboratory and identification of a research problem, and submission of an individual development plan that is revisited quarterly. Participants will attend monthly career development workshops, weekly scientific seminars and laboratory meetings, present updates on their research at quarterly work-in-progress meetings, and present their research at multiple local and one national meeting. They will take one graduate level course in the fall and spring semester, and will be provided a GRE preparatory course. Each participant will have a research committee comprised of their mentor, a faculty member from the Advisory Committee, and another faculty member so that knowledgeable letters of recommendation can be written on their behalf. Participants will be carefully mentored through the graduate school application and interview processes. In order to maximize the mentoring experience and foster learning environments that are conducive to inclusive excellence, mentors will participate in professional development seminars that will focus on cross-cultural mentoring. In addition, the institution will cover the costs of visits by five gradute program directors each year to highlight the program, showcase its participants and develop pipelines to top programs. The participants will be integrated into the activities of first-year graduate students. Metrics of success for the initial 5 years include the number of participants who apply for and are accepted in a graduate program, that author or co-author a publication, the number of invitations received to interview and the quality of those programs, and the number who eventually secure independent funding by appointment to T32 or F31 mechanisms. Mentors, participants and programs into which the participants matriculate will be surveyed annually for feedback and as a means to track the career paths of our participants. The program will undergo continual assessment so that it can adapt to the needs of the participants.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ayotunde Oluropo Dokun其他文献

Ayotunde Oluropo Dokun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ayotunde Oluropo Dokun', 18)}}的其他基金

This proposed R13 application will focus on Endocrinology, Diabetes and Metabolism, HIV/AIDS, Gastroenterology, Cardiology, Pulmonology, Nephrology, and Oncology subspecialty topics.
拟议的 R13 应用程序将重点关注内分泌学、糖尿病和代谢、艾滋病毒/艾滋病、胃肠病学、心脏病学、肺病学、肾病学和肿瘤学亚专业主题。
  • 批准号:
    10320631
  • 财政年份:
    2021
  • 资助金额:
    $ 24.68万
  • 项目类别:
This proposed R13 application will focus on Endocrinology, Diabetes and Metabolism, HIV/AIDS, Gastroenterology, Cardiology, Pulmonology, Nephrology, and Oncology subspecialty topics.
拟议的 R13 应用程序将重点关注内分泌学、糖尿病和代谢、艾滋病毒/艾滋病、胃肠病学、心脏病学、肺病学、肾病学和肿瘤学亚专业主题。
  • 批准号:
    10704520
  • 财政年份:
    2021
  • 资助金额:
    $ 24.68万
  • 项目类别:
This proposed R13 application will focus on Endocrinology, Diabetes and Metabolism, HIV/AIDS, Gastroenterology, Cardiology, Pulmonology, Nephrology, and Oncology subspecialty topics.
拟议的 R13 应用程序将重点关注内分泌学、糖尿病和代谢、艾滋病毒/艾滋病、胃肠病学、心脏病学、肺病学、肾病学和肿瘤学亚专业主题。
  • 批准号:
    10445337
  • 财政年份:
    2021
  • 资助金额:
    $ 24.68万
  • 项目类别:
Improving Health Disparities by Building an Equitable Future for Communities through Research and Practice
通过研究和实践为社区建立公平的未来,改善健康差距
  • 批准号:
    9399520
  • 财政年份:
    2017
  • 资助金额:
    $ 24.68万
  • 项目类别:
Modulation of miR29a and ADAM12 to improve peripheral arterial disease
调节 miR29a 和 ADAM12 以改善外周动脉疾病
  • 批准号:
    10094744
  • 财政年份:
    2016
  • 资助金额:
    $ 24.68万
  • 项目类别:
Modulation of miR29a and ADAM12 to improve peripheral arterial disease outcomes in diabetes
调节 miR29a 和 ADAM12 可改善糖尿病外周动脉疾病的预后
  • 批准号:
    9265932
  • 财政年份:
    2016
  • 资助金额:
    $ 24.68万
  • 项目类别:
Reducing Health Disparities in Internal Medicine with a focus on Endocrinology, Diabetes, and Metabolism, HIV/AIDS, Pulmonology, Gastroenterology, Cardiology, and Nephrology subspecialty topics.
减少内科医学的健康差异,重点关注内分泌学、糖尿病和新陈代谢、艾滋病毒/艾滋病、肺病学、胃肠病学、心脏病学和肾脏病学亚专业主题。
  • 批准号:
    9195049
  • 财政年份:
    2016
  • 资助金额:
    $ 24.68万
  • 项目类别:
Modulation of miR29a and ADAM12 to improve peripheral arterial disease outcomes in diabetes
调节 miR29a 和 ADAM12 可改善糖尿病外周动脉疾病的预后
  • 批准号:
    9008921
  • 财政年份:
    2016
  • 资助金额:
    $ 24.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了